CRSR
Corsair Gaming, Inc.
CRSR's outlook is improving, though it still trails on the overall score.
MSFT
Microsoft Corporation
MSFT has the edge over CRSR overall, supported by lower modeled downside and stronger valuation.
CRSR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
CRSR's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
CRSR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 16x | $12.28 | — |
| Cheap | 18x | $7.00 | -43% |
| Fair | 30x | $11.35 | -7.5% |
| Current | 32x | $12.28 | — |
| Expensive | 99x | $37.59 | +206% |
Historical ranges are pointers, not guarantees.
CRSR's PE is in its fair range at 32x. If earnings grow as analysts expect, today's price would be 16x next year's earnings, in its cheap range.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT has the edge over CRSR in the historical PE scenario, which offers more potential upside but is not a forecast.
CRSR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
CRSR has the edge over MSFT on the outlook, with more favorable profitability expectations.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for MSFT, with profitability holding steady.
CRSR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.79 | +107% |
| Q3 2026 | $0.38 | +$0.72 |
| Q2 2026 | $0.31 | +$1.12 |
| Q1 2026 | $0.09 | +$1.02 |
| Q4 2025 | -$0.12 | +$0.83 |
| Q3 2025 | -$0.34 | +$0.62 |
| Q2 2025 | -$0.81 | -$0.38 |
| Q1 2025 | -$0.93 | -$0.79 |
| Q4 2024 | -$0.95 | -$0.92 |
CRSR has returned to profit: it earned $0.38 per share over the past year, after losing money the year before.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT has the edge over CRSR on earnings, with more consistent year-over-year improvement.
CRSR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $367M | +6.1% |
| Q2 2026 | $314.3M | -1.8% |
| Q1 2026 | $354.5M | -4.1% |
| Q4 2025 | $436.9M | +5.6% |
| Q3 2025 | $345.8M | +14% |
| Q2 2025 | $320.1M | +23% |
| Q1 2025 | $369.8M | +9.6% |
| Q4 2024 | $413.6M | -0.9% |
CRSR's revenue is recovering but still below its 2020 peak: $367M last quarter, up 6.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.5% | +1.2 points |
| Q2 2026 | 2.4% | +7.7 points |
| Q1 2026 | 3.9% | +4.5 points |
| Q4 2025 | 6.2% | +4.7 points |
| Q3 2025 | -1.6% | +5.3 points |
| Q2 2025 | -5.3% | +4.2 points |
| Q1 2025 | -0.6% | +2.4 points |
| Q4 2024 | 1.4% | -1.5 points |
CRSR's operating margin was −0.5% last quarter, up 1.2 points from the same quarter a year ago.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT has the edge over CRSR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT has the edge over CRSR on profitability, with a higher operating margin.
CRSR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$16.7M | +$24.6M |
| Q2 2026 | $72.1M | +162% |
| Q1 2026 | $26.1M | +66% |
| Q4 2025 | $32.9M | -39% |
| Q3 2025 | -$41.3M | -290% |
| Q2 2025 | $27.5M | +$48.5M |
| Q1 2025 | $15.7M | +$44.5M |
| Q4 2024 | $54.1M | -1.9% |
CRSR has the edge over MSFT on cash flow, with more consistent year-over-year improvement.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT's free cash flow has been positive every quarter for seven years: $60B over the past year, down 23% from the year before.
CRSR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -487K shares |
| 1 year | +2.3% | +2.4M shares |
| 3 years | +5.7% | +5.8M shares |
| 5 years | +8.7% | +8.7M shares |
| Available history | +18% | +16.9M shares |
CRSR has 109M diluted shares, up 2.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $5M |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | $962,000 |
MSFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -7M shares |
| 1 year | -0.3% | -20M shares |
| 3 years | -0.2% | -16M shares |
| 5 years | -1.6% | -121M shares |
| Available history | -3.2% | -245M shares |
MSFT has the edge over CRSR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4B |
| Q2 2026 | $4.6B |
| Q1 2026 | $4.6B |
| Q4 2025 | $7.4B |
| Q3 2025 | $5.7B |
| Q2 2025 | $4.5B |
| Q1 2025 | $4.8B |
| Q4 2024 | $5B |
MSFT spent $21B buying back its own shares over the past year, up 5.2% from the year before.
CRSR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -1.3x | Net Cash |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | 1.5x | Healthy |
| Q2 2024 | 11.2x | High |
| Q1 2024 | 1.4x | Healthy |
| Q4 2023 | 0.4x | Very low |
| Q3 2023 | 1.3x | Healthy |
CRSR has the edge over MSFT on leverage, with a lower net debt burden relative to earnings.
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT's net debt is less than a year of its operating earnings (EBITDA).
CRSR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.5 | Neutral |
| Stochastic | 40.1 | Neutral |
CRSR's weekly RSI is 55 (neutral) and its Stochastic is 40 (neutral).
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
CRSR PE vs Technology Sector
| Metric | CRSR | Sector median | Relative |
|---|---|---|---|
| PE | 32x | 28x | 16% above |
| PE % | 55 | 38 | 17 pts above |
CRSR is trading at 32x earnings, a 16% premium to the Technology sector's median of 28x.
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT has the edge over CRSR on valuation relative to its sector.
CRSR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.0 | 5.8% below |
| 20 week MA | $12.2 | 1.1% above |
| 50 week MA | $8.83 | 39% above |
| 100 week MA | $8.67 | 42% above |
| 200 week MA | $10.8 | 14% above |
CRSR has slipped below its 8-week average, but it's still above the other four, and 14% above its 200-week average.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT's trend is up, with a small recent dip: it's below only its 8-week average, and 27% above its 200-week average.
CRSR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.3 | $36.4 | +111% |
| 2021 | $36.4 | $22.4 | -38% |
| 2022 | $22.4 | $13.7 | -39% |
| 2023 | $13.7 | $14.1 | +2.6% |
| 2024 | $14.1 | $6.55 | -54% |
| 2025 | $6.55 | $6.10 | -6.9% |
| 2026 YTD | $6.10 | $12.3 | +101% |
CRSR has the edge over MSFT on returns for 2026, with the stronger performance.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has finished higher in five of the last six years, two of them by more than 50%. It's up 7.2% so far in 2026.